EP3113772

TRÍFLÚRÓMETÝL-SETIN PÝRASÓLEFNI SEM PLASMA-KALLIKREIN-HEMLAR ÚR MÖNNUM

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    9.3.2015
  • EP published:
    9.9.2020
  • EP application number:
    15759254.4
  • Max expiry date:
    8.3.2035
  • Expiry date:
    8.3.2027
  • Next due date:
    31.3.2027
  • Title:
    TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS

Timeline

Today
9.3.2015EP application
9.9.2020EP Publication
7.12.2020Translation submitted
15.1.2021Registration published
8.3.2027Expires

Owner

  • Name:
    Biocryst Pharmaceuticals, Inc.
  • Address:
    4505 Emperor Blvd., Durham, North Carolina 27703, US

Inventor

  • Name:
    KOTIAN, Pravin L.
  • Address:
    Hoover, AL 35226, US
  • Name:
    BABU, Yarlagadda S.
  • Address:
    Birmingham, AL 35244, US
  • Name:
    WU, Minwan
  • Address:
    Vestavia Hills, AL 35226, US
  • Name:
    CHINTAREDDY, Venkat R.
  • Address:
    Vestavia Hills, AL 35216, US
  • Name:
    KUMAR, V. Satish
  • Address:
    Birmingham, AL 35244, US
  • Name:
    ZHANG, Weihe
  • Address:
    Vestavia, AL 35226, US

Agent

  • Name:
    Budde Schou A/S
  • Address:
    Dronningens Tværgade 30, DK

Priority

  • Number:
    201461949808 P
  • Date:
    7.3.2014
  • Country:
    US
  • Number:
    201461981515 P
  • Date:
    18.4.2014
  • Country:
    US

Classification

  • Categories:
    C07D 403/12, C07D 401/14, C07D 231/14, C07D 401/04, C07D 403/04, C07D 405/12, C07D 413/04, C07D 413/12, C07D 417/12, A61P 7/02, A61K 31/415

Annual fees

Number

Paid

Expires

Payer

Number: 7

Paid: 8.2.2021

Expires: 8.3.2022

Payer: Árnason Faktor ehf.

Number: 8

Paid: 8.2.2022

Expires: 8.3.2023

Payer: Árnason Faktor ehf.

Number: 9

Paid: 8.2.2023

Expires: 8.3.2024

Payer: Árnason Faktor ehf.

Number: 10

Paid: 22.1.2024

Expires: 8.3.2025

Payer: Pintz & Partners LLC

Number: 11

Paid: 20.1.2025

Expires: 8.3.2026

Payer: UAB METIDA

Number: 12

Paid: 20.1.2026

Expires: 8.3.2027

Payer: UAB METIDA

Upload documents